Lv1
30 积分 2025-03-25 加入
Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant A Randomized Clinical Trial
14小时前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
16天前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
19天前
已完结
Diagnosis and Treatment of Metastatic Colorectal Cancer A Review
25天前
已完结
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
1个月前
已完结
Ovarian cancer
1个月前
已完结
Ovarian cancer
1个月前
已完结
The next generation of immunotherapies for lung cancers
2个月前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
2个月前
已完结
皖公网安备34019202002308
